Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
EchoIQ Limited ( (AU:EIQ) ) just unveiled an update.
EchoIQ Limited has been added to the S&P/ASX All Ordinaries Index as part of S&P Dow Jones Indices’ March 2026 quarterly rebalance, effective before the market opens on March 23, 2026. The inclusion places EchoIQ alongside a broad group of emerging and established companies, potentially enhancing its market visibility, liquidity, and appeal to index-tracking and institutional investors as it strengthens its position in the medical technology space.
The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.66 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
EchoIQ Limited operates in the medical technology sector, focusing on diagnostic solutions for cardiovascular and related health conditions. The company develops and applies advanced analytical tools to improve the accuracy and efficiency of medical imaging assessments, targeting clinicians and healthcare providers in markets where early and precise diagnosis is critical.
Average Trading Volume: 2,491,240
Technical Sentiment Signal: Buy
Current Market Cap: A$455.5M
For an in-depth examination of EIQ stock, go to TipRanks’ Overview page.